BridgeMD
New treatment option for Obesity and Overweight
Official title Overweight and Obesity in Adolescents - Sleep Behavioral Intervention
ClinicalTrials.gov ID: NCT07255274
What this study is testing
- What it's testing
- Sleep plays a crucial role in energy balance, alongside diet and physical activity. Research has linked poor sleep quality and short sleep duration to obesity and cardiometabolic risk, such as insulin resistance and hypertension.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 13 to 17
You may be able to join if
- Informed consent from legal guardians and assent/consent from the adolescent;
- Age between 13 and 17 years at the time of consent;
- Diagnosis of overweight (BMI z-score \> 1 and ≤ 2) or obesity (BMI z-score \> 2), according to WHO criteria;
- Sleep deprivation or poor sleep quality, based on the initial screening questionnaire.
You likely can't join if
- Secondary obesity (e.g., hypothalamic, genetic, or endocrine causes);
- Comorbid psychiatric or neurological disorders (e.g., epilepsy, autism spectrum disorder) that affect sleep;
- Current treatment with selective serotonin reuptake inhibitors (SSRIs) or other medications affecting sleep.
The study team makes the final eligibility decision.
Where it's taking place
- Covilha, Portugal
- Porto, Portugal
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 13 years to 17 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Covilha, Portugal; Porto, Portugal. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.